US2004133063A1PendingUtilityA1

Methods and devices for improving cardiac function in hearts

Assignee: MYOCORPriority: Jan 2, 1997Filed: Dec 12, 2003Published: Jul 8, 2004
Est. expiryJan 2, 2017(expired)· nominal 20-yr term from priority
A61B 2017/0445A61B 17/1227A61B 17/00234A61B 17/0487A61B 2017/00243A61B 2017/0404A61B 2017/0496A61B 2017/0458A61B 2017/0435A61B 2017/0464A61B 2017/0454A61B 2017/0446A61F 2/2481A61B 17/04A61B 2090/392A61B 2017/048A61F 2/2487A61B 90/39
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Various methods and devices are disclosed for improving cardiac function in hearts having zones of infarcted (akinetic) and aneurysmal (dyskinetic) tissue regions. The methods and devices reduce the radius of curvature in walls of the heart proximal infarcted and aneurysmal regions to reduce wall stress and improve pumping efficiency. The inventive methods and related devices include splinting of the chamber wall proximal the infarcted region and various other devices and methods including suture and patch techniques.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for direct localized therapeutic treatment of myocardial tissue in heart having a pathological condition comprising the steps of: 
 a. identifying a target region of the myocardium;    b. applying material directly and substantially only to at least a portion of the myocardial tissue of the target region substantially identified in step (a) to physically modify the mechanical properties of said tissue.    
     
     
         2 . The method of  claim 1 , wherein the modified mechanical properties include an increase in systolic performance.  
     
     
         3 . The method of  claim 1 , wherein the modified mechanical properties include substantially no decrease in global diastolic performance.  
     
     
         4 . The method of  claim 1 , wherein the material applied is passive.  
     
     
         5 . The method of  claim 1 , wherein said target region includes a myocardial infarct.  
     
     
         6 . The method of  claim 1 , wherein said target region at least in part underlies the papillary muscles associated with a cardiac valve.  
     
     
         7 . The method of  claim 6 , wherein said cardiac valve is the mitral valve.  
     
     
         8 . The method of  claim 1 , wherein said material applied to the myocardial tissue is a device.  
     
     
         9 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a polymer.  
     
     
         10 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a bioactive agent.  
     
     
         11 . The method of  claim 1 , wherein said applying step is preceded by performing a mini-thoracotomy.  
     
     
         12 . The method of  claim 1 , wherein said applying step includes applying material intramyocardially.  
     
     
         13 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a tension member having a first end and a second end, each of said ends provided with an anchor member.  
     
     
         14 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a braided ring.  
     
     
         15 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a plurality of sutures.  
     
     
         16 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a suture having two free ends and wherein the applying step comprises suturing said suture substantially around a perimeter of said portion of the myocardial tissue and pulling said two free ends to draw said portion of the myocardial tissue together substantially toward a center of said portion of the myocardial tissue.  
     
     
         17 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises an enclosure member having a first configuration and a second configuration and wherein the applying step comprises positioning said enclosure member around said portion of myocardial tissue while said enclosure member is in the first configuration and securing said enclosure member to the myocardial tissue after said positioning step, wherein said enclosure member reconfigures to the second configuration after said securing step.  
     
     
         18 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a plurality of sutures each having first and second ends, each of said first ends adapted to be attached to points on said myocardial tissue, and an enclosure member defining a space therein, wherein said plurality of sutures extend through said space, and wherein said second ends are adapted to be attached to points on said myocardial tissue located outside said space.  
     
     
         19 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises an enclosure member adapted to assume a first configuration during application of said enclosure member to said portion of myocardial tissue, and to assume a second configuration after application of said enclosure member to said portion of myocardial tissue to draw said portion of tissue toward a center of the enclosure member.  
     
     
         20 . The method of  claim 1 , wherein said material applied to the myocardial tissue comprises a biocompatible adhesive.  
     
     
         21 . The method of  claim 1 , wherein said applying step comprises applying said material completely externally of the myocardium.  
     
     
         22 . A method for direct localized therapeutic treatment of myocardial tissue in heart having a athological condition comprising the steps of: 
 a. identifying a target region of the myocardium;    b. advancing an element across the septum of the heart to deliver material; and    C. applying said material directly and substantially only to at least a portion of the myocardial tissue of the target region substantially identified in step (a) to physically modify the mechanical properties of said tissue.    
     
     
         23 . The method of  claim 22 , wherein the modified mechanical properties include an increase in systolic performance.  
     
     
         24 . The method of  claim 23 , wherein the modified mechanical properties include substantially no decrease in global diastolic performance.  
     
     
         25 . The method of  claim 22 , wherein the material applied is passive.  
     
     
         26 . The method of  claim 22 , wherein said target region includes a myocardial infarct.  
     
     
         27 . The method of  claim 22 , wherein said target region at least in part underlies the papillary muscles associated with a cardiac valve.  
     
     
         28 . The method of  claim 27 , wherein said cardiac valve is the mitral valve.  
     
     
         29 . The method of  claim 22 , wherein said material applied to the myocardial tissue is a device.  
     
     
         30 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a polymer.  
     
     
         31 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a bioactive agent.  
     
     
         32 . The method of  claim 22 , wherein said applying step is preceded by performing a mini-thoracotomy.  
     
     
         33 . The method of  claim 22 , wherein said applying step includes applying material intramyocardially.  
     
     
         34 . The method of  claim 22 , further comprising the step of performing an additional therapeutic or diagnostic procedure either before or after said applying step employing access to the heart gained during said advancing step.  
     
     
         35 . The method of  claim 34 , wherein said additional therapeutic or diagnostic procedure is one or more procedures selected from the set consisting of pressure monitoring, angiography, ablation, placement of pacing leads, electrophysiology mapping, and placement of LVAD cannulae.  
     
     
         36 . The method of  claim 22 , wherein said advancing step comprises advancing an element across the ventricular septum of the heart.  
     
     
         37 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a tension member having a first end and a second end, each of said ends provided with an anchor member.  
     
     
         38 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a braided ring.  
     
     
         39 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a plurality of sutures.  
     
     
         40 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a suture having two free ends and wherein the applying step comprises suturing said suture substantially around a perimeter of said portion of the myocardial tissue and pulling said two free ends to draw said portion of the myocardial tissue together substantially toward a center of said portion of the myocardial tissue.  
     
     
         41 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises an enclosure member having a first configuration and a second configuration and wherein the applying step comprises positioning said enclosure member around said portion of myocardial tissue while said enclosure member is in the first configuration and securing said enclosure member to the myocardial tissue after said positioning step, wherein said enclosure member reconfigures to the second configuration after said securing step.  
     
     
         42 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a plurality of sutures each having first and second ends, each of said first ends adapted to be attached to points on said myocardial tissue, and an enclosure member defining a space therein, wherein said plurality of sutures extend through said space, and wherein said second ends are adapted to be attached to points on said myocardial tissue located outside said space.  
     
     
         43 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises an enclosure member adapted to assume a first configuration during application of said enclosure member to said portion of myocardial tissue, and to assume a second configuration after application of said enclosure member to said portion of myocardial tissue to draw said portion of tissue toward a center of the enclosure member.  
     
     
         44 . The method of  claim 22 , wherein said material applied to the myocardial tissue comprises a biocompatible adhesive.  
     
     
         45 . The method of  claim 22 , wherein said applying step comprises applying said material completely externally of the myocardium.

Join the waitlist — get patent alerts

Track US2004133063A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.